Crinetics Pharmaceuticals Inc
NASDAQ:CRNX

Watchlist Manager
Crinetics Pharmaceuticals Inc Logo
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Watchlist
Price: 49.31 USD 2.6% Market Closed
Market Cap: 4.7B USD

Wall Street
Price Targets

CRNX Price Targets Summary
Crinetics Pharmaceuticals Inc

Wall Street analysts forecast CRNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CRNX is 81.75 USD with a low forecast of 45.45 USD and a high forecast of 113.4 USD.

Lowest
Price Target
45.45 USD
8% Downside
Average
Price Target
81.75 USD
66% Upside
Highest
Price Target
113.4 USD
130% Upside
Crinetics Pharmaceuticals Inc Competitors:
Price Targets
KALV
Kalvista Pharmaceuticals Inc
87% Upside
TNG
Transgene SA
83% Upside
VTGN
VistaGen Therapeutics Inc
274% Upside
PHARM
Pharming Group NV
36% Upside
SKYE
Skye Bioscience Inc
673% Upside
2142
Hbm Holdings Ltd
2% Upside
ALNY
Alnylam Pharmaceuticals Inc
20% Upside
ALKS
Alkermes Plc
53% Upside

Revenue
Forecast

Revenue Estimate
Crinetics Pharmaceuticals Inc

For the last 7 years the compound annual growth rate for Crinetics Pharmaceuticals Inc's revenue is -9%. The projected CAGR for the next 3 years is 468%.

-9%
Past Growth
468%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Crinetics Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Crinetics Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CRNX's stock price target?
Price Target
81.75 USD

According to Wall Street analysts, the average 1-year price target for CRNX is 81.75 USD with a low forecast of 45.45 USD and a high forecast of 113.4 USD.

What is Crinetics Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
468%

For the last 7 years the compound annual growth rate for Crinetics Pharmaceuticals Inc's revenue is -9%. The projected CAGR for the next 3 years is 468%.

Back to Top